The University of Southampton
University of Southampton Institutional Repository

Design of polymer systems and surface-active agents for the improvement of cell attachment for treatment of ocular diseases

Design of polymer systems and surface-active agents for the improvement of cell attachment for treatment of ocular diseases
Design of polymer systems and surface-active agents for the improvement of cell attachment for treatment of ocular diseases
The degradation of eyesight is a frightening experience for individuals and unfortunately gradual loss of vision with old age is commonplace. One of the most common forms of eye disease which effects vision is Age-Related Macular Degeneration (AMD). AMD is the leading cause of blindness in the developed world and there is currently no cure for the disease. One treatment option available for the neovascular form of AMD is the injection of Bevacizumab [an anti-vascular endothelial growth factor (VEGF) drug] into the eye on a monthly basis.
Investigation into the biodegradable polymers poly(L-lactic acid) (PLLA) and poly(D,L-lactic-co-glycolic acid) (PLGA) as a possible drug delivery system with highly uniform and reproducible microspheres was developed. Under optimised parameters Bevacizumab-encapsulated PLLA:PLGA microspheres were successfully prepared with a steady release of Bevacizumab being obtained.
Additionally, fibrous scaffolds of methyl methacrylate (MMA) and poly(ethylene glycol) methacrylate (PEGM) were prepared by an electrospinning process. These MMA:PEGM co-polymers were investigated as a possible Bruchs membrane replacement and as the support for retinal pigment epithelium (RPE) transplantation. The MMA:PEGM co-polymers were functionalised with N-succinimidyl which resulted in the fibres forming a gel in vitro. Gel formation was examined further and successful RPE cell attachment and growth onto these gels was observed. Further work on surface active agents was undertaken to improve the cell adhesion, proliferation and growth of RPE cells onto these methacrylate based frameworks. An arginine-glycine-aspartic acid (RGD) peptidomimetic was prepared and reacted onto the surface of the MMA:PEGM co-polymers, however, the peptidomimetic-attached MMA:PEGM fibres offered little improvement in cell growth in comparison with N-succinimidyl–activated MMA:PEGM co-polymer fibres.
Additional attachment of the natural proteins laminin, collagen and fibronectin onto the microspheres was achieved. Attachment of these proteins prolonged the release of the dye from the microspheres and showed no cytotoxic effects when examined in-vitro.
Pitt, Darren William
54e007c9-cd15-4a7a-982b-6732b7a2a382
Pitt, Darren William
54e007c9-cd15-4a7a-982b-6732b7a2a382
Grossel, Martin
403bf3ff-6364-44e9-ab46-52d84c6f0d56

(2015) Design of polymer systems and surface-active agents for the improvement of cell attachment for treatment of ocular diseases. University of Southampton, Chemistry, Doctoral Thesis, 233pp.

Record type: Thesis (Doctoral)

Abstract

The degradation of eyesight is a frightening experience for individuals and unfortunately gradual loss of vision with old age is commonplace. One of the most common forms of eye disease which effects vision is Age-Related Macular Degeneration (AMD). AMD is the leading cause of blindness in the developed world and there is currently no cure for the disease. One treatment option available for the neovascular form of AMD is the injection of Bevacizumab [an anti-vascular endothelial growth factor (VEGF) drug] into the eye on a monthly basis.
Investigation into the biodegradable polymers poly(L-lactic acid) (PLLA) and poly(D,L-lactic-co-glycolic acid) (PLGA) as a possible drug delivery system with highly uniform and reproducible microspheres was developed. Under optimised parameters Bevacizumab-encapsulated PLLA:PLGA microspheres were successfully prepared with a steady release of Bevacizumab being obtained.
Additionally, fibrous scaffolds of methyl methacrylate (MMA) and poly(ethylene glycol) methacrylate (PEGM) were prepared by an electrospinning process. These MMA:PEGM co-polymers were investigated as a possible Bruchs membrane replacement and as the support for retinal pigment epithelium (RPE) transplantation. The MMA:PEGM co-polymers were functionalised with N-succinimidyl which resulted in the fibres forming a gel in vitro. Gel formation was examined further and successful RPE cell attachment and growth onto these gels was observed. Further work on surface active agents was undertaken to improve the cell adhesion, proliferation and growth of RPE cells onto these methacrylate based frameworks. An arginine-glycine-aspartic acid (RGD) peptidomimetic was prepared and reacted onto the surface of the MMA:PEGM co-polymers, however, the peptidomimetic-attached MMA:PEGM fibres offered little improvement in cell growth in comparison with N-succinimidyl–activated MMA:PEGM co-polymer fibres.
Additional attachment of the natural proteins laminin, collagen and fibronectin onto the microspheres was achieved. Attachment of these proteins prolonged the release of the dye from the microspheres and showed no cytotoxic effects when examined in-vitro.

PDF
D Pitt Thesis.pdf - Other
Download (4MB)

More information

Published date: 25 June 2015
Organisations: University of Southampton, Chemistry

Identifiers

Local EPrints ID: 380880
URI: http://eprints.soton.ac.uk/id/eprint/380880
PURE UUID: 24d95b7f-808f-4290-913e-f4fde757fb29
ORCID for Martin Grossel: ORCID iD orcid.org/0000-0001-7469-6854

Catalogue record

Date deposited: 28 Aug 2015 11:36
Last modified: 25 Jun 2018 04:01

Export record

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×